Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
August Moretti Insider Profile
4 Followers
August Moretti, CFO & SVP at Assertio Therapeutics, holds 74.45K shares in Assertio Therapeutics (Ticker: ASRT), holds 192.11K shares in Alexza Pharmaceuticals (Ticker: ALXA).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+49.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO & SVP
Roles that August Moretti holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 17, 2013 - May 17, 2014
Return:+99.40%
The most profitable trade made by August Moretti
August Moretti's Trading History
Assertio Therapeutics
Apr 03, 2018
CFO & SVP
Uninformative Sell
45.97K
$30.82K
Alexza Pharmaceuticals
Jan 21, 2011
―
Uninformative Buy
―
$179.62K
List of latest transactions for each holding click on a transaction to see August Moretti's performance on stock
You May Also Like
August Moretti insider profile FAQ
What is the percentage of profitable transactions made by August Moretti?
The percentage of profitable transactions made by August Moretti is 50%.
What is the average return per transaction made by August Moretti?
The average return per transaction made by August Moretti is 49.00%.
What stocks does August Moretti hold?
August Moretti holds: ASRT, ALXA stocks.
What was August Moretti’s latest transaction?
August Moretti latest transaction was an Uninformative Sell of $45.97K.
What was August Moretti's most profitable transaction?
August Moretti’s most profitable transaction was an Informative Buy of ASRT stock on May 17, 2013. The return on the trade was 99.40%.
What is August Moretti's role in Assertio Therapeutics?
August Moretti's role in Assertio Therapeutics is CFO & SVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.